CSIMarket
 
Oramed Pharmaceuticals Inc   (ORMP)
Other Ticker:  
 
 

Oramed Pharmaceuticals Inc Growth Comparisons

Select each growth Category to receive further Information



ORMP Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 1.2 % 12.56 % 6.14 % -0 %
Q / Q Revenue Growth (Q1 MRQ) 0 % 3.75 % -2.68 % -9.1 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 5.32 % 4.07 % 4.24 % %
Seq. Revenue Growth (for 12 months ending Q1 TTM) 0.3 % 2.22 % 1.3 % -0.13 %
Revenue 5 Year Average Growth - 11.8 % 11.83 % 10.72 %
Expected Revenue Growth (Y/Y) - 2.5 % 1.89 % 1.03 %


ORMP's Growth Comparisons in II. Quarter 2020




Although the Major Pharmaceutical Preparations industry saw advancing Revenue by 12.56%, Oramed Pharmaceuticals Inc announced 1.2% year on year sales decline in the second quarter 2020, to $ 1 millions, and underperformed the 6.14% Revenue growth in the Healthcare sector. Above average sales gains in Healthcare and Major Pharmaceutical Preparations industry, helped to elevate overall market growth to -0%.

Sequentially company's Revenue were unchanged from the first quarter results. . Looking into annual growth, sales grew by % on average in last five years, while S & P 500's including only Businesses with the second quarter 2020 earnings reports, average yearly sales growth is 10.72%.


Growth Rates of ORMP's Income in the second quarter 2020


ORMP Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) 13.14 % 12.5 % 4.81 % -13.89 %
Seq. Operating Income Change (Q1 MRQ) 66.2 % 140.22 % 20.96 % -40.4 %
Y / Y Operating Income Growth (Q1 TTM) -18.9 % 45.89 % 444.41 % 2.72 %
Seq. Operating Income Growth (Q1 TTM) 3.78 % 3.15 % 1.22 % -2.94 %
Operating Income 5 Year Avg. Change 19.89 % 8.58 % -0.45 % 7.74 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) -0.35 % -0.97 % 1.88 % -44.24 %
Seq. Income from Cont. Ops. Change (Q1 MRQ) 45.03 % 237.17 % 6.28 % -44.3 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) -17.67 % 46.49 % 38.87 % -12.44 %
Seq. Income from Cont. Ops. Change (Q1 TTM) -0.1 % 0.54 % 0.85 % -10.91 %
Income from Cont. Ops. 5 Year Avg. Change 20.31 % 7.49 % 5.43 % 35.89 %

ORMP Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) -0.35 % -25.19 % -13.83 % -44.08 %
Q / Q Net Income Growth (Q1 MRQ) 45.03 % 222.77 % 6.07 % -41.51 %
Y / Y Net Income Change (Q1 TTM) -17.67 % 29.05 % 29.74 % -13.72 %
Seq. Net Income Change (Q1 TTM) -0.1 % -7.65 % -3.67 % -11.3 %
Net Income 5 Year Avg. Growth 20.31 % 8.5 % 6.04 % 36.79 %

ORMP's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) 0 % -10.21 % 1.88 % -44.24 %
Seq. EPS from Cont. Ops. Change (Q1 MRQ) 40 % 250.46 % 6.28 % -44.3 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) -23.28 % - - -
Seq. EPS from Cont. Ops. Change (Q1 TTM) 0 % - - -75.53 %
EPS from Cont. Ops. 5 Year Avg. Growth 5.75 % -0.39 % 5.43 % 35.89 %



ORMP EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) 0 % -32.17 % -13.83 % -44.08 %
Q / Q EPS Net Growth (Q1 MRQ) 40 % 235.5 % 6.07 % -41.51 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - -73.89 %
Seq. EPS Net Change (for 12 months ending Q1 TTM) 0 % - - -74.53 %
EPS Net 5 Year Avg. Change 5.75 % 8.5 % 6.04 % 36.79 %
Expected EPS Growth (Y/Y) - - 123.59 % 17.19 %



Reporting flat EPS in the second quarter, at $ 0.21, Oramed Pharmaceuticals Inc performing better than the -32.17% Major Pharmaceutical Preparations industry, and less than -13.83% fall in the Healthcare sector. Above average income per share gains in Healthcare and Major Pharmaceutical Preparations industry, helped to elevate overall market growth to -44.08%.

Company's sequential bottom-line increase was 40% from the first quarter. Average annual income per share rise for Oramed Pharmaceuticals Inc is 5.75%, while S & P 500's average yearly income per share growth is 36.79% over the five years, including only Businesses with the second quarter 2020 earnings results.

ORMP Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - 51.25 % 23.86 % -18.89 %
Seq. Free Cash Flow Change (Q1 MRQ) - -45.41 % -48.12 % -89.02 %
Y / Y Free Cash Flow Change (Q1 TTM) - 9.09 % 8.7 % 11.1 %
Seq. Free Cash Flow Change (Q1 TTM) - 5.09 % 2.68 % -1.17 %
Free Cash Flow 5 Year Avg. Change - 6.46 % 7.07 % 15.72 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - - -
Seq. Net Cash Flow Change (Q1 MRQ) - - -73.98 % 729.98 %
Y / Y Net Cash Flow Change (Q1 TTM) 1769.4 % 1794.31 % 2280.44 % -
Seq. Net Cash Flow Change (Q1 TTM) - 2812.64 % 74.08 % 968.16 %
Net Cash Flow 5 Year Avg. Change - - 61.02 % 523.07 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) - 14.27 % -2.51 % -3.63 %
Seq. Capital Expenditures Change (Q1 MRQ) - -24.19 % -24.07 % -26.91 %
Y / Y Capital Expenditures Change (Q1 TTM) 0 % 8.42 % 1.94 % 4.29 %
Seq. Capital Expenditures Change (Q1 TTM) 0 % 2.8 % 0.89 % -0.4 %
Capital Expenditures 5 Year Avg. Change - 13.18 % 22.72 % 13.39 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 





       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NA's Profile

Stock Price

NA's Financials

Business Description

Fundamentals

Charts & Quotes

NA's News

Suppliers

NA's Competitors

Customers & Markets

Economic Indicators

NA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071